Adagio Medical Holdings (ADGM) Change in Accured Expenses (2023 - 2026)

Adagio Medical Holdings has disclosed Change in Accured Expenses across 4 years of filings, most recently posting -$495000.0 for Q2 2026.

• In Q2 2026, Change in Accured Expenses fell 304.55% year-over-year to -$495000.0; the TTM figure through Jun 2026 stood at -$1.6 million (down 425.97% YoY), while the FY2025 annual figure was $3.3 million, up 2498.43% from the prior year.
• Change in Accured Expenses came in at -$495000.0 for Q2 2026 at Adagio Medical Holdings, down from $135000.0 in the prior quarter.
• In the past five years, Change in Accured Expenses ranged from a high of $678000.0 in Q1 2024 to a low of -$1.5 million in Q4 2025.
• Average Change in Accured Expenses over 4 years is -$298250.0, with a median of -$355500.0 recorded in 2023.
• The largest YoY upside for Change in Accured Expenses was 123.4% in 2026 against a maximum downside of 304.55% in 2026.
• Over 4 years, Change in Accured Expenses stood at -$216000.0 in 2023, then sank by 201.39% to -$651000.0 in 2024, then sank by 130.72% to -$1.5 million in 2025, then surged by 67.04% to -$495000.0 in 2026.
• Per Business Quant data, the three most recent Change in Accured Expenses figures were -$495000.0 in Q2 2026, $135000.0 in Q1 2026, and -$1.5 million in Q4 2025.